<\/p>\n
\u00a0\u00a0<\/p>\n
Therapy for Pediatric Clients with Mood Disorders<\/strong><\/p>\n BACKGROUND INFORMATION<\/strong><\/p>\n The client is an 8-year-old African American male who arrives at the ER with his mother. He is exhibiting signs of depression.<\/p>\n \u00b7 \u00a0Client complained of feeling \u201csad\u201d<\/strong><\/p>\n \u00b7 \u00a0Mother reports that teacher said child is withdrawn from peers in class<\/strong><\/p>\n \u00b7 \u00a0Mother notes decreased appetite and occasional periods of irritation<\/strong><\/p>\n \u00b7 \u00a0Client reached all developmental landmarks at appropriate ages<\/strong><\/p>\n \u00b7 \u00a0Physical exam unremarkable<\/strong><\/p>\n \u00b7 \u00a0Laboratory studies WNL<\/strong><\/p>\n \u00b7 \u00a0Child referred to psychiatry for Assessment<\/strong><\/p>\n \u00b7 \u00a0Client seen by Psychiatric Nurse Practitioner<\/strong><\/p>\n \u00a0 MENTAL STATUS EXAM<\/p>\n Alert & oriented X 3, speech clear, coherent, goal directed, spontaneous. Self-reported mood is \u201csad\u201d. Affect somewhat blunted, but child smiled appropriately at various points throughout the clinical interview. He denies visual or auditory hallucinations. No delusional or paranoid thought processes noted. Judgment and insight appear to be age-appropriate. He is not endorsing active suicidal ideation, but does admit that he often thinks about himself being dead and what it would be like to be dead ( Depression is diagnosed).<\/p>\n The Assignment<\/strong><\/p>\n Examine Case Study: An African American Child Suffering From Depression<\/em>. You will be asked to make three decisions concerning the medication to prescribe to this client. Be sure to consider factors that might impact the client\u2019s pharmacokinetic and pharmacodynamic processes.<\/p>\n \u00b7 At each decision point stop to complete the following:<\/p>\n \u00b7 \u00a0<\/p>\n o Decision #1<\/p>\n \u00a7 Which decision did you select?<\/p>\n \u00a7 Why did you select this decision? Support your response with evidence and references to the Learning Resources.<\/p>\n \u00a7 What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources.<\/p>\n \u00a7 Explain any difference between what you expected to achieve with Decision #1 and the results of the decision. Why were they different?<\/p>\n \u00a7 \u00a0<\/p>\n o Decision #2<\/p>\n \u00a7 Why did you select this decision? Support your response with evidence and references to the Learning Resources.<\/p>\n \u00a7 What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources.<\/p>\n \u00a7 Explain any difference between what you expected to achieve with Decision #2 and the results of the decision. Why were they different?<\/p>\n \u00a7 \u00a0<\/p>\n o Decision #3<\/p>\n \u00a7 Why did you select this decision? Support your response with evidence and references to the Learning Resources.<\/p>\n \u00a7 What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources.<\/p>\n \u00a7 Explain any difference between what you expected to achieve with Decision #3 and the results of the decision. Why were they different?<\/p>\n \u00b7 Also include how ethical considerations might impact your treatment plan and communication with clients.<\/p>\n Hint ( available on the required media on resource below)<\/strong><\/p>\n Decision 1; begin Zoloft 25mg orally( Pt has no change)<\/p>\n Decision 2; increase dose to 37.5 mg orally ( Little effect of 20%)<\/p>\n Decision 3; increase dose to 75 mg orally ( pt feeling better. Will maintain this dose).\u00a0<\/p>\n Other option, Begin paxil ( pt has N\/V\/D, refused meds), Begin Welbutrin( pt unable to sleep).<\/p>\n Resources for reference<\/p>\n \u00a0Lorberg, B., \u00a0Davico, C., \u00a0Martsenkovskyi, D., & Vitiello, B. (2019). \u00a0Principles in using psychotropic medication in children and adolescents. In J. M. Rey & A. Martin (Eds.), IACAPAP e-Textbook of Child and Adolescent Mental Health<\/em>. Geneva: International Association for Child and Adolescent Psychiatry and Allied Professions. Retrieved from https:\/\/iacapap.org\/content\/uploads\/A.7-Psychopharmacology-2019.1.pdf<\/a><\/p>\n Magellan Health, Inc. (2013). Appropriate use of psychotropic drugs in children and adolescents: A clinical monograph. Retrieved from http:\/\/www.magellanhealth.com\/media\/445492\/magellan-psychotropicdrugs-0203141.pdf<\/a><\/p>\n Poznanski, E., & Mokros, H. (1996). Child Depression Rating Scale–Revised. Los Angeles, CA: Western Psychological Services.<\/p>\n Note: <\/strong>Retrieved from Walden Library databases.<\/p>\n Rao, U. (2013). Biomarkers in pediatric depression. Depression & Anxiety, 30<\/em>(9), 787-791. doi:10.1002\/da.22171<\/a><\/p>\n Required Media<\/p>\n
\u00a0<\/p>\n